Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-17 4:49 pm Purchase | 2021-05-05 | 13G | Spruce Biosciences, Inc. SPRB | Flynn James E | 1,419,651 6.090% | 1,419,651 (New Position) | Filing History |
| 2021-05-07 4:56 pm Purchase | 2021-04-27 | 13G | KalVista Pharmaceuticals, Inc. KALV | Flynn James E | 1,806,037 7.430% | 1,806,037 (New Position) | Filing History |
| 2021-05-04 12:33 pm Purchase | 2021-05-04 | 13G | Werewolf Therapeutics, Inc. HOWL | Flynn James E | 2,552,787 9.270% | 2,552,787 (New Position) | Filing History |
| 2021-04-09 1:19 pm Purchase | 2021-03-30 | 13G | Wave Life Sciences Ltd. WVE | Flynn James E | 3,910,430 7.980% | 3,910,430 (New Position) | Filing History |
| 2021-03-30 3:40 pm Purchase | 2021-03-30 | 13G | Edgewise Therapeutics, Inc. EWTX | Flynn James E | 3,933,137 8.270% | 3,933,137 (New Position) | Filing History |
| 2021-03-17 11:01 am Purchase | 2021-03-15 | 13G | Xeris Biopharma Holdings, Inc. XERS | Flynn James E | 12,435,751 9.880% | 6,553,398 (+111.41%) | Filing History |
| 2021-02-22 4:45 pm Unchanged | 2021-02-18 | 13D | HIGHCAPE CAP ACQUISITION CRP U CAPAU | Flynn James E | 1,000,000 8.400% | 0 (Unchanged) | Filing History |
| 2021-02-12 12:41 pm Sale | 2020-12-31 | 13G | DBV Technologies S.A. DBVT | Flynn James E | 0 0.000% | -118,900 (Position Closed) | Filing History |
| 2021-02-12 12:40 pm Sale | 2020-12-31 | 13G | Alimera Sciences, Inc. ALIM | Flynn James E | 0 0.000% | -676,667 (Position Closed) | Filing History |
| 2021-02-12 12:39 pm Sale | 2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Flynn James E | 457,500 2.730% | -449,437 (-49.56%) | Filing History |
| 2021-02-12 12:39 pm Sale | 2020-12-31 | 13G | AVEO Pharmaceuticals, Inc. AVEO | Flynn James E | 0 0.000% | -1,574,000 (Position Closed) | Filing History |
| 2021-02-12 12:38 pm Sale | 2020-12-31 | 13G | Vericel Corporation VCEL | Flynn James E | 64,946 0.140% | -2,682,617 (-97.64%) | Filing History |
| 2021-02-12 12:37 pm Sale | 2020-12-31 | 13G | Vapotherm, Inc. VAPO | Flynn James E | 75,565 2.360% | -63,889 (-45.81%) | Filing History |
| 2021-02-12 12:37 pm Purchase | 2020-12-31 | 13G | Sientra, Inc. SIEN | Flynn James E | 1,655,226 4.985% | 1,232,458 (+291.52%) | Filing History |
| 2021-02-12 12:36 pm Sale | 2020-12-31 | 13G | Nkarta, Inc. NKTX | Flynn James E | 1,419,872 4.360% | -1,000,000 (-41.32%) | Filing History |
| 2021-02-12 12:35 pm Sale | 2020-12-31 | 13G | Neuronetics, Inc. STIM | Flynn James E | 919,000 11.000% | -156,000 (-14.51%) | Filing History |
| 2021-02-12 12:35 pm Purchase | 2020-12-31 | 13G | Intersect ENT, Inc. XENT | Flynn James E | 4,438,213 4.985% | 1,641,180 (+58.68%) | Filing History |
| 2021-02-12 12:34 pm Sale | 2020-12-31 | 13G | Cabaletta Bio, Inc. CABA | Flynn James E | 464,252 1.930% | -1,164,252 (-71.49%) | Filing History |
| 2021-02-12 12:33 pm Sale | 2020-12-31 | 13G | Axonics, Inc. AXNX | Flynn James E | 800,000 2.010% | -994,594 (-55.42%) | Filing History |
| 2021-02-12 12:32 pm Sale | 2020-12-31 | 13G | Ardelyx, Inc. ARDX | Flynn James E | 10,246,216 2.840% | -17,770,796 (-63.43%) | Filing History |